Ralph Fritsch

Papers

Total Citations

H-Index

About

Ralph Fritsch is a leading surgical oncologist whose research focuses on the multidisciplinary management of colorectal liver metastases (CRLM), a condition affecting half of all colorectal cancer patients. His most-cited work, "Multimodal treatment strategies for colorectal liver metastases" (2021, 21 citations), addresses the critical challenge that untreated CRLM carries a near-zero five-year survival rate. Fritsch’s major contribution lies in advancing the evidence for surgical resection as the sole curative option, while systematically evaluating how to integrate chemotherapy, ablation, and biologic therapies to expand resectability and improve outcomes. His research synthesizes complex treatment algorithms, helping to clarify when and how to combine modalities for maximum patient benefit. Beyond this landmark paper, Fritsch has been instrumental in refining perioperative protocols and advocating for personalized, stage-adapted strategies. His work directly impacts clinical guidelines and offers a roadmap for oncologists navigating the difficult balance between aggressive surgical intervention and systemic disease control—a vital contribution to a field where survival gains remain hard-won.